Sfoglia per Rivista
Impact of ABO incompatibility on patientsâ outcome after haploidentical hematopoietic stem cell transplantation for acute myeloid leukemia-a report from the acute leukemia working party of the EBMT
2017-01-01 Canaani, Jonathan; Savani, Bipin N.; Labopin, Myriam; Huang, Xiao Jun; Ciceri, Fabio; Arcese, William; Tischer, Johanna; Koc, Yener; Bruno, Benedetto; Gã¼lbas, Zafer; Blaise, Didier; Maertens, Johan; Ehninger, Gerhard; Mohty, Mohamad; Nagler, Arnon
Impact of idelalisib on health-related quality of life in patients with relapsed chronic lymphocytic leukemia in a phase III randomized trial
2020-01-01 Ghia, P.; Coutre, S. E.; Cheson, B. D.; Barrientos, J. C.; Hillmen, P.; Pettitt, A. R.; Zelenetz, A. D.; Shreay, S.; Hallek, M.; Furman, R. R.
IN ADULT ACUTE MYELOID LEUKAEMIA (AML) ALL RISK SUBSETS BENEFIT FROM A SEQUENTIAL HIGH-DOSE PROGRAMME AS EARLY RESCUE OF FIRST INDUCTION FAILURE: A REPORT FROM NORTHERN ITALY LEUKAEMIA GROUP (NILG)
2010-01-01 Intermesoli, T; Rossi, G; Pogliani, E; Marmont, F; Cavattoni, I; Cassibba, V; Scattolin, A; Musso, M; Mattei, D; Minotto, C; Ciceri, Fabio; Campiotti, L; Corradini, P; Borlenghi, E; Ruggeri, G; Terruzzi, E; Verga, L; Audisio, E; Fabris, P; Chisesi, T; Giussani, U; Spinelli, O; Zanghi, P; Oldani, E; Barbui, T; Rambaldi, A; Bassan, R.
In vitro and in vivo activity of the VEGF inhibitor pazopanib
2007-01-01 Podar, K; Tonon, G; Sattler, M; Tai, Yt; Legouill, S; Yasui, H; Ishitsuka, K; Kumar, S; Kumar, R; Pandite, Ln; Hideshima, T; Chauhan, D; Anderson, Kc
IN VITRO CHARACTERISTICS OF HEMATOPOIETIC PROGENITORS FROM PRIMARY MYELOFIBROSIS PATIENTS CORRELATE WITH IPSS/DIPSS RISK CATEGORY
2015-01-01 Masselli, Elena; Carubbi, Cecilia; Gobbi, Giuliana; Mirandola, Prisco; Galli, Daniela; Martini, Silvia; Pozzi, Giulia; Gildone, Maria; Albanese, Cristina; Bonomini, Sabrina; Crugnola, Monica; Craviotto, Luisa; Aversa, Franco; Vitale, Marco
Increased TG lymphocytes in a case of Congenital Hypoplastic Anemia (Blackfan-Diamond Syndrome)
1980-01-01 CORNAGLIA FERRARIS, P.; Mori, P. G.; Debernardi, B.; Pasino, M.; Ghio, R.; Sitia, Roberto; Massimo, L.
Infliximab treatment for steroid-refactory acutes graft-versus-host disease
2004-01-01 Patriarca, F; Sperotto, A; Damiani, D; Morreale, G; Bonifazi, F; Olivieri, A; Ciceri, Fabio; Milone, G; Cesaro, S; Bandini, G; Dini, G; Corradini, P; Fanin, R.
Infrequent "chronic lymphocytic leukemia-specific" immunoglobulin stereotypes in aged individuals with or without low count monoclonal B cell lymphocytosis
2021-01-01 Agathangelidis, Andreas; Galigalidou, Chrysi; Scarfò, Lydia; Moysiadis, Theodoros; Rovida, Alessandra; Gounari, Maria; Psomopoulos, Fotis; Ranghetti, Pamela; Galanis, Alex; Davi, Frederic; Stamatopoulos, Kostas; Chatzidimitriou, Anastasia; Ghia, Paolo
INHIBITION OF THE STK4 KINASE RESTORES THE HIPPO CO-FACTOR YAP1 AND INDUCES DNA-DAMAGE MEDIATED APOPTOSIS IN MULTIPLE MYELOMA CELLS
2014-01-01 Cottini, F; Hideshima, T; Xu, C; Ponzoni, M; Richardson, P; Cappio, Fc; Anderson, K; Tonon, G
Innovation in the prognostication of chronic lymphocytic leukemia: how far beyond TP53 gene analysis can we go?
2016-01-01 Pospisilova, S; Sutton, La; Malcikova, J; Tausch, E; Rossi, D; Montserrat, E; Moreno, C; Stamatopoulos, K; Gaidano, G; Rosenquist, R; Ghia, P
INTENSIVE TREATMENT OF ELDERLY PATIENTS WITH ACUTE MYELOID LEUKEMIA OR MYELODYSPLASTIC SYNDROME: A SINGLE CENTER EXPERIENCE
2009-01-01 Crotta, A; Tassara, M; Messina, C; Malato, S; Ciceri, Fabio; Bernardi, M.
Interleukin 2 and mitogen driven proliferation in human peripheral mononuclear cells: a kinetic analysis
1989-01-01 Ferrero, E; Manfredi, ANGELO ANDREA M. A.; Bianchi, E; Schönheit, A; Sabbadini, Mg; Rugarli, C.
International multicenter retrospective analysis of thiotepa-based autologous stem cell transplantation for secondary central nervous system lymphoma
2023-01-01 Khwaja, J.; Kirkwood, A. A.; Isbell, L. K.; Steffanoni, S.; Goradia, H.; Pospiech, L.; Fail, T.; Nicholson, E.; Fletcher, K.; Linton, K. M.; Parsons, K. E.; Elmusharaf, N.; Eccersley, L.; Eyre, T. A.; Chaganti, S.; Smith, J.; Thakrar, N.; Kutilina, A.; Calimeri, T.; Martinez-Calle, N.; El-Sharkawi, D.; Osborne, W.; Illerhaus, G.; Fox, C. P.; Ferreri, A. J. M.; Schorb, E.; Cwynarski, K.
Iron increases the susceptibility of multiple myeloma cells to bortezomib
2013-01-01 Campanella, A; Santambrogio, P; Fontana, F; Frenquelli, M; Cenci, S; Marcatti, M; Sitia, Roberto; Tonon, G; Camaschella, Clara
Iron refractory iron deficiency anemia
2013-01-01 DE FALCO, L; Sanchez, M; Silvestri, L; Kannengiesser, C; Muckenthaler, Mu; Iolascon, A; Gouya, L; Camaschella, Clara; Beaumont, C.
Isolated bone marrow occurrence of classic Hodgkin's lymphoma in an HIV-negative patient
2006-01-01 Ponzoni, Maurilio; Ciceri, Fabio; Crocchiolo, R; Famoso, G; Doglioni, C.
Italian Society of Hematology practice guidelines for the management of iron overload in thalassemia major and related disorders
2008-01-01 Angelucci, E; Barosi, G; Camaschella, Clara; Cappellini, Md; Cazzola, M; Galanello, R; Marchetti, M; Piga, A; Tura, S.
JUNB, DUSP2, SGK1, SOCS1 and CREBBP are frequently mutated in T-cell/histiocyterich large B-cell lymphoma
2019-01-01 Schuhmacher, B.; Bein, J.; Rausch, T.; Benes, V.; Tousseyn, T.; Vornanen, M.; Ponzoni, M.; Thurner, L.; Gascoyne, R.; Steidl, C.; Kuppers, R.; Hansmann, M. -L.; Hartmann, S.
KMT2D mutations and TP53 disruptions are poor prognostic biomarkers in mantle cell lymphoma receiving high-dose therapy: A FIL study
2020-01-01 Ferrero, S.; Rossi, D.; Rinaldi, A.; Bruscaggin, A.; Spina, V.; Eskelund, C. W.; Evangelista, A.; Moia, R.; Kwee, I.; Dahl, C.; Di Rocco, A.; Stefoni, V.; Diop, F.; Favini, C.; Ghione, P.; Mahmoud, A. M.; Schipani, M.; Kolstad, A.; Barbero, D.; Novero, D.; Paulli, M.; Zamo, A.; Jerkeman, M.; Da Silva, M. G.; Santoro, A.; Molinari, A.; Ferreri, A.; Gronbaek, K.; Piccin, A.; Cortelazzo, S.; Bertoni, F.; Ladetto, M.; Gaidano, G.
LEUKEMIA RELAPSE AFTER ALLOGENENIC HSCT DISPLAYS A DISTINCTIVE IMMUNE-RELATED SIGNATURE, WITH FUNCTIONALLY RELEVANT ALTERATIONS IN HLA CLASS II ANTIGEN PRESENTATION AND T CELL COSTIMULATION
2015-01-01 Toffalori, C; Riba, M; Zito, L; Oliveira, G; Bucci, G; Barcella, M; Spinelli, O; Crucitti, L; Cieri, N; Cittaro, D; Lazarevic, D; Peccatori, J; Bernardi, M; Bonini, C; Rambaldi, A; Barlassina, C; Stupka, E; Bianchi, M; Ciceri, F; Fleischhauer, K; Vago, L
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Impact of ABO incompatibility on patientsâ outcome after haploidentical hematopoietic stem cell transplantation for acute myeloid leukemia-a report from the acute leukemia working party of the EBMT | 1-gen-2017 | Canaani, Jonathan; Savani, Bipin N.; Labopin, Myriam; Huang, Xiao Jun; Ciceri, Fabio; Arcese, William; Tischer, Johanna; Koc, Yener; Bruno, Benedetto; Gã¼lbas, Zafer; Blaise, Didier; Maertens, Johan; Ehninger, Gerhard; Mohty, Mohamad; Nagler, Arnon | |
| Impact of idelalisib on health-related quality of life in patients with relapsed chronic lymphocytic leukemia in a phase III randomized trial | 1-gen-2020 | Ghia, P.; Coutre, S. E.; Cheson, B. D.; Barrientos, J. C.; Hillmen, P.; Pettitt, A. R.; Zelenetz, A. D.; Shreay, S.; Hallek, M.; Furman, R. R. | |
| IN ADULT ACUTE MYELOID LEUKAEMIA (AML) ALL RISK SUBSETS BENEFIT FROM A SEQUENTIAL HIGH-DOSE PROGRAMME AS EARLY RESCUE OF FIRST INDUCTION FAILURE: A REPORT FROM NORTHERN ITALY LEUKAEMIA GROUP (NILG) | 1-gen-2010 | Intermesoli, T; Rossi, G; Pogliani, E; Marmont, F; Cavattoni, I; Cassibba, V; Scattolin, A; Musso, M; Mattei, D; Minotto, C; Ciceri, Fabio; Campiotti, L; Corradini, P; Borlenghi, E; Ruggeri, G; Terruzzi, E; Verga, L; Audisio, E; Fabris, P; Chisesi, T; Giussani, U; Spinelli, O; Zanghi, P; Oldani, E; Barbui, T; Rambaldi, A; Bassan, R. | |
| In vitro and in vivo activity of the VEGF inhibitor pazopanib | 1-gen-2007 | Podar, K; Tonon, G; Sattler, M; Tai, Yt; Legouill, S; Yasui, H; Ishitsuka, K; Kumar, S; Kumar, R; Pandite, Ln; Hideshima, T; Chauhan, D; Anderson, Kc | |
| IN VITRO CHARACTERISTICS OF HEMATOPOIETIC PROGENITORS FROM PRIMARY MYELOFIBROSIS PATIENTS CORRELATE WITH IPSS/DIPSS RISK CATEGORY | 1-gen-2015 | Masselli, Elena; Carubbi, Cecilia; Gobbi, Giuliana; Mirandola, Prisco; Galli, Daniela; Martini, Silvia; Pozzi, Giulia; Gildone, Maria; Albanese, Cristina; Bonomini, Sabrina; Crugnola, Monica; Craviotto, Luisa; Aversa, Franco; Vitale, Marco | |
| Increased TG lymphocytes in a case of Congenital Hypoplastic Anemia (Blackfan-Diamond Syndrome) | 1-gen-1980 | CORNAGLIA FERRARIS, P.; Mori, P. G.; Debernardi, B.; Pasino, M.; Ghio, R.; Sitia, Roberto; Massimo, L. | |
| Infliximab treatment for steroid-refactory acutes graft-versus-host disease | 1-gen-2004 | Patriarca, F; Sperotto, A; Damiani, D; Morreale, G; Bonifazi, F; Olivieri, A; Ciceri, Fabio; Milone, G; Cesaro, S; Bandini, G; Dini, G; Corradini, P; Fanin, R. | |
| Infrequent "chronic lymphocytic leukemia-specific" immunoglobulin stereotypes in aged individuals with or without low count monoclonal B cell lymphocytosis | 1-gen-2021 | Agathangelidis, Andreas; Galigalidou, Chrysi; Scarfò, Lydia; Moysiadis, Theodoros; Rovida, Alessandra; Gounari, Maria; Psomopoulos, Fotis; Ranghetti, Pamela; Galanis, Alex; Davi, Frederic; Stamatopoulos, Kostas; Chatzidimitriou, Anastasia; Ghia, Paolo | |
| INHIBITION OF THE STK4 KINASE RESTORES THE HIPPO CO-FACTOR YAP1 AND INDUCES DNA-DAMAGE MEDIATED APOPTOSIS IN MULTIPLE MYELOMA CELLS | 1-gen-2014 | Cottini, F; Hideshima, T; Xu, C; Ponzoni, M; Richardson, P; Cappio, Fc; Anderson, K; Tonon, G | |
| Innovation in the prognostication of chronic lymphocytic leukemia: how far beyond TP53 gene analysis can we go? | 1-gen-2016 | Pospisilova, S; Sutton, La; Malcikova, J; Tausch, E; Rossi, D; Montserrat, E; Moreno, C; Stamatopoulos, K; Gaidano, G; Rosenquist, R; Ghia, P | |
| INTENSIVE TREATMENT OF ELDERLY PATIENTS WITH ACUTE MYELOID LEUKEMIA OR MYELODYSPLASTIC SYNDROME: A SINGLE CENTER EXPERIENCE | 1-gen-2009 | Crotta, A; Tassara, M; Messina, C; Malato, S; Ciceri, Fabio; Bernardi, M. | |
| Interleukin 2 and mitogen driven proliferation in human peripheral mononuclear cells: a kinetic analysis | 1-gen-1989 | Ferrero, E; Manfredi, ANGELO ANDREA M. A.; Bianchi, E; Schönheit, A; Sabbadini, Mg; Rugarli, C. | |
| International multicenter retrospective analysis of thiotepa-based autologous stem cell transplantation for secondary central nervous system lymphoma | 1-gen-2023 | Khwaja, J.; Kirkwood, A. A.; Isbell, L. K.; Steffanoni, S.; Goradia, H.; Pospiech, L.; Fail, T.; Nicholson, E.; Fletcher, K.; Linton, K. M.; Parsons, K. E.; Elmusharaf, N.; Eccersley, L.; Eyre, T. A.; Chaganti, S.; Smith, J.; Thakrar, N.; Kutilina, A.; Calimeri, T.; Martinez-Calle, N.; El-Sharkawi, D.; Osborne, W.; Illerhaus, G.; Fox, C. P.; Ferreri, A. J. M.; Schorb, E.; Cwynarski, K. | |
| Iron increases the susceptibility of multiple myeloma cells to bortezomib | 1-gen-2013 | Campanella, A; Santambrogio, P; Fontana, F; Frenquelli, M; Cenci, S; Marcatti, M; Sitia, Roberto; Tonon, G; Camaschella, Clara | |
| Iron refractory iron deficiency anemia | 1-gen-2013 | DE FALCO, L; Sanchez, M; Silvestri, L; Kannengiesser, C; Muckenthaler, Mu; Iolascon, A; Gouya, L; Camaschella, Clara; Beaumont, C. | |
| Isolated bone marrow occurrence of classic Hodgkin's lymphoma in an HIV-negative patient | 1-gen-2006 | Ponzoni, Maurilio; Ciceri, Fabio; Crocchiolo, R; Famoso, G; Doglioni, C. | |
| Italian Society of Hematology practice guidelines for the management of iron overload in thalassemia major and related disorders | 1-gen-2008 | Angelucci, E; Barosi, G; Camaschella, Clara; Cappellini, Md; Cazzola, M; Galanello, R; Marchetti, M; Piga, A; Tura, S. | |
| JUNB, DUSP2, SGK1, SOCS1 and CREBBP are frequently mutated in T-cell/histiocyterich large B-cell lymphoma | 1-gen-2019 | Schuhmacher, B.; Bein, J.; Rausch, T.; Benes, V.; Tousseyn, T.; Vornanen, M.; Ponzoni, M.; Thurner, L.; Gascoyne, R.; Steidl, C.; Kuppers, R.; Hansmann, M. -L.; Hartmann, S. | |
| KMT2D mutations and TP53 disruptions are poor prognostic biomarkers in mantle cell lymphoma receiving high-dose therapy: A FIL study | 1-gen-2020 | Ferrero, S.; Rossi, D.; Rinaldi, A.; Bruscaggin, A.; Spina, V.; Eskelund, C. W.; Evangelista, A.; Moia, R.; Kwee, I.; Dahl, C.; Di Rocco, A.; Stefoni, V.; Diop, F.; Favini, C.; Ghione, P.; Mahmoud, A. M.; Schipani, M.; Kolstad, A.; Barbero, D.; Novero, D.; Paulli, M.; Zamo, A.; Jerkeman, M.; Da Silva, M. G.; Santoro, A.; Molinari, A.; Ferreri, A.; Gronbaek, K.; Piccin, A.; Cortelazzo, S.; Bertoni, F.; Ladetto, M.; Gaidano, G. | |
| LEUKEMIA RELAPSE AFTER ALLOGENENIC HSCT DISPLAYS A DISTINCTIVE IMMUNE-RELATED SIGNATURE, WITH FUNCTIONALLY RELEVANT ALTERATIONS IN HLA CLASS II ANTIGEN PRESENTATION AND T CELL COSTIMULATION | 1-gen-2015 | Toffalori, C; Riba, M; Zito, L; Oliveira, G; Bucci, G; Barcella, M; Spinelli, O; Crucitti, L; Cieri, N; Cittaro, D; Lazarevic, D; Peccatori, J; Bernardi, M; Bonini, C; Rambaldi, A; Barlassina, C; Stupka, E; Bianchi, M; Ciceri, F; Fleischhauer, K; Vago, L |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile